Compounds > cv 3988
Page last updated: 2024-08-26

cv 3988 and Inhalation Injury, Smoke

cv 3988 has been researched along with Inhalation Injury, Smoke in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikeuchi, H; Mason, AD; Pruitt, BA; Sakano, T; Sanchez, J1
Cioffi, WG; Ikeuchi, H; Mason, AD; Pruitt, BA; Shimazu, T1

Other Studies

2 other study(ies) available for cv 3988 and Inhalation Injury, Smoke

ArticleYear
The effects of platelet-activating factor (PAF) and a PAF antagonist (CV-3988) on smoke inhalation injury in an ovine model.
    The Journal of trauma, 1992, Volume: 32, Issue:3

    Topics: Animals; Dinoprostone; Lipid Peroxidation; Male; Malondialdehyde; Phospholipid Ethers; Platelet Activating Factor; Platelet Count; Sheep; Smoke Inhalation Injury; Thromboxane B2; Time Factors

1992
Evaluation and management of patients with inhalation injury.
    The Journal of trauma, 1990, Volume: 30, Issue:12 Suppl

    Topics: Animals; Burns, Inhalation; Humans; Lung; Models, Biological; Oxygen; Phospholipid Ethers; Platelet Activating Factor; Sheep; Smoke Inhalation Injury

1990